Fair pricing in community pharmacy reimbursement required.
This bill requires community pharmacies in Minnesota to receive reimbursement for prescription drugs that is at least equal to the National Average Drug Acquisition Cost or Wholesale Acquisition Cost, plus a professional dispensing fee adjusted for inflation and operational costs. It directly affects pharmacy benefit managers, managed care organizations, and community pharmacies by prohibiting below-cost reimbursements, banning negative adjustments like transaction fees, and ensuring PBM-owned pharmacies cannot receive higher rates than independent community pharmacies for the same prescriptions. The law also excludes federal 340B program participants from these reimbursement requirements, allowing them to follow existing federal and state rules instead.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 2, 2026
Last action Apr 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
0
Mar 2, 2026
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 3922
Scope: MN
Hi! I can help you understand HF 3922. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline